Difference between revisions of "Folic acid (Folate)"
Jump to navigation
Jump to search
m |
|||
| (One intermediate revision by one other user not shown) | |||
| Line 4: | Line 4: | ||
''No known antineoplastic properties. Used to mitigate the toxicity of the folate antagonists [[Methotrexate (MTX)]] and [[Pralatrexate (Folotyn)]]'' | ''No known antineoplastic properties. Used to mitigate the toxicity of the folate antagonists [[Methotrexate (MTX)]] and [[Pralatrexate (Folotyn)]]'' | ||
| − | [[Category: | + | ==Also known as== |
| + | *'''Generic name:''' folate | ||
| + | |||
| + | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Oral medications]] | [[Category:Oral medications]] | ||
[[Category:Chemotherapy protective agents]] | [[Category:Chemotherapy protective agents]] | ||
Latest revision as of 12:34, 4 December 2022
Mechanism of action
Diseases for which it is used
No known antineoplastic properties. Used to mitigate the toxicity of the folate antagonists Methotrexate (MTX) and Pralatrexate (Folotyn)
Also known as
- Generic name: folate